Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR-320c by targeting Runx2
Jilong Zou
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorJianyang Du
Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorHualei Tu
Department of Burn, The Fifth Hospital in Harbin, Harbin, China
Search for more papers by this authorHongjun Chen
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorKai Cong
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorZhenggang Bi
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorCorresponding Author
Jiabing Sun
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Correspondence
Jiabing Sun, Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Email: [email protected]
Search for more papers by this authorJilong Zou
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorJianyang Du
Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorHualei Tu
Department of Burn, The Fifth Hospital in Harbin, Harbin, China
Search for more papers by this authorHongjun Chen
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorKai Cong
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorZhenggang Bi
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Search for more papers by this authorCorresponding Author
Jiabing Sun
Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
Correspondence
Jiabing Sun, Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Email: [email protected]
Search for more papers by this authorAbstract
Bone marrow mesenchymal stem cells (BMSCs) are a potential source of osteoblasts and have been widely used in clinical therapies due to their pluripotency. Recent publications have found that resveratrol (RSVL) played a crucial role in the proliferation and differentiation of BMSCs; however, the underlying molecular mechanism of RSVL-induced BMSCs osteogenic differentiation needs to be fully elucidated. The objective of this study was to explore functions of miRNAs in the RSVL-treated BMSCs and its effects on the differentiation potentials of BMSCs. The findings demonstrated that RSVL enhanced the osteogenesis and suppressed the adipogenesis of BMSCs in a dose-dependent manner. Besides, a novel regulatory axis containing miR-320c, and its target Runx2 was found during the differentiation process of BMSCs under RSVL treatment. Increase of miR-320c reduced the osteogenic potential of BMSCs, while knockdown of miR-320c played a positive role in the osteogenesis of BMSCs. In contrast, overexpression of miR-320c accelerated the adipogenic differentiation, while knockdown of miR-320c restrained the adipogenic differentiation of BMSCs. The results confirmed that Runx2 might be the direct target of miR-320c in RSVL-promoted osteogenic differentiation of BMSCs. This study revealed that RSVL might be used for the treatment of bone loss related diseases and miR-320c could be regarded as a novel and potential target to regulate the biological functions of BMSCs.
CONFLICT OF INTEREST
The authors indicated no potential conflicts of interest.
Supporting Information
Filename | Description |
---|---|
term3176-sup-0001-suppl-data.doc6 MB | Supporting Information S1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- Alkhalaf, M., & Jaffal, S. (2006). Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade. Free Radical Biology and Medicine, 41, 318–325.
- Cai, H., Yang, X., Gao, Y., Xu, Z., Yu, B., Xu, T., … Hua, L. (2019). Exosomal MicroRNA-9-3p secreted from BMSCs downregulates ESM1 to suppress the development of bladder cancer. Molecular Therapy—Nucleic Acids, 18, 787–800.
- Cao, X., Luo, T., Luo, X., & Tang, Z. (2014). Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice. Hypertension Research, 37, 803–810.
- Chakraborty, S., Levenson, A. S., & Biswas, P. K. (2013). Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha. BMC Structural Biology, 13, 27.
- Chaudhary, Z., Subramaniam, S., Khan, G. M., Abeer, M. M., Qu, Z., Janjua, T., … Popat, A. (2019). Encapsulation and controlled release of resveratrol within functionalized mesoporous silica nanoparticles for prostate cancer therapy. Frontiers in Bioengineering and Biotechnology, 7, 225.
- Chen, X. H., Shi, Z. G., Lin, H. B., Wu, F., Zheng, F., Wu, C. F., & Huang, M. W. (2019). Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells. European Review for Medical and Pharmacological Sciences, 23, 6352–6359.
- Colbath, A. C., Kisiday, J., Phillips, J., & Goodrich, L. R. (2019). Can extracorporeal shockwave promote osteogenesis of equine bone marrow-derived mesenchymal stem cells in vitro? Stem Cells and Development, 29, 110–118.
- De-Ugarte, L., Yoskovitz, G., Balcells, S., Guerri-Fernandez, R., Martinez-Diaz, S., Mellibovsky, L., … Diez-Perez, A. (2015). MiRNA profiling of whole trabecular bone: Identification of osteoporosis-related changes in MiRNAs in human hip bones. BMC Medical Genomics, 8, 75.
- Deng, L., Hu, G., Jin, L., Wang, C., & Niu, H. (2018). Involvement of microRNA-23b in TNF-alpha-reduced BMSC osteogenic differentiation via targeting runx2. Journal of Bone and Mineral Metabolism, 36, 648–660.
- Deng, Y., Wu, S., Zhou, H., Bi, X., Wang, Y., Hu, Y., … Fan, X. (2013). Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. Stem Cells and Development, 22, 2278–2286.
- Domazetovic, V., Fontani, F., Tanini, D., D'esopo, V., Viglianisi, C., Marcucci, G., … Iantomasi, T. (2017). Protective role of benzoselenophene derivatives of resveratrol on the induced oxidative stress in intestinal myofibroblasts and osteocytes. Chemico-Biological Interactions, 275, 13–21.
- Garcia-Quiroz, J., Garcia-Becerra, R., Santos-Cuevas, C., Ramirez-Nava, G. J., Morales-Guadarrama, G., Cardenas-Ochoa, N., … Diaz, L. (2019). Synergistic antitumorigenic activity of calcitriol with curcumin or resveratrol is mediated by angiogenesis inhibition in triple negative breast cancer xenografts. Cancers (Basel), 11, 1739.
- Hamam, D., Ali, D., Vishnubalaji, R., Hamam, R., Al-Nbaheen, M., Chen, L., … Alajez, N. M. (2014). microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. Cell Death & Disease, 5, e1499.
- He, J., Li, Z., Yu, T., Wang, W., Tao, M., Wang, S., … Ao, Q. (2019). In Vitro and in Vivo biocompatibility study on acellular sheep periosteum for guided bone regeneration. Biomedical Materials, 15, 015013.
- Hu, N., Feng, C., Jiang, Y., Miao, Q., & Liu, H. (2015). Regulative effect of mir-205 on osteogenic differentiation of bone mesenchymal stem cells (BMSCs): Possible role of SATB2/runx2 and ERK/MAPK pathway. International Journal of Molecular Sciences, 16, 10491–10506.
- Huang, J., Zhao, L., Xing, L., & Chen, D. (2010). MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells, 28, 357–364.
- Huang, Y., Hou, Q., Su, H., Chen, D., Luo, Y., & Jiang, T. (2019). miR488 negatively regulates osteogenic differentiation of bone marrow mesenchymal stem cells induced by psoralen by targeting Runx2. Molecular Medicine Reports, 20, 3746–3754.
- Inoue, K., Deng, Z., Chen, Y., Giannopoulou, E., Xu, R., Gong, S., … Zhao, B. (2018). Bone protection by inhibition of microRNA-182. Nature Communications, 9, 4108.
- Iwagami, Y., Eguchi, H., Nagano, H., Akita, H., Hama, N., Wada, H., … Doki, Y. (2013). miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. British Journal of Cancer, 109, 502–511.
- Jeandet, P., Sobarzo-Sanchez, E., Silva, A. S., Clement, C., Nabavi, S. F., Battino, M., … Nabavi, S. M. (2019). Whole-cell biocatalytic, enzymatic and green chemistry methods for the production of resveratrol and its derivatives. Biotechnology Advances, 39, 107461.
- Ji, Q., Liu, X., Han, Z., Zhou, L., Sui, H., Yan, L., … Li, Q. (2015). Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-beta1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer, 15, 97.
- Jiang, Z., Wang, H., Yu, K., Feng, Y., Wang, Y., Huang, T., … Yang, G. (2017). Light-controlled BMSC sheet-implant complexes with improved osteogenesis via an LRP5/beta-catenin/runx2 regulatory loop. ACS Applied Materials & Interfaces, 9, 34674–34686.
- Won Lee, G., Thangavelu, M., Joung Choi, M., Yeong Shin, E., Sol Kim, H., Seon Baek, J., … Khang, G. (2020). Exosome mediated transfer of miRNA-140 promotes enhanced chondrogenic differentiation of bone marrow stem cells for enhanced cartilage repair and regeneration. Journal of Cellular Biochemistry, 121, 3642–3652.
- Li, C. J., Xiao, Y., Yang, M., Su, T., Sun, X., Guo, Q., … Luo, X. H. (2018). Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging. Journal of Clinical Investigation, 128, 5251–5266.
- Li, K. C., Chang, Y. H., Yeh, C. L., & Hu, Y. C. (2016). Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges. Biomaterials, 74, 155–166.
- Li, J., Xin, Z., & Cai, M. (2019). The role of resveratrol in bone marrow-derived mesenchymal stem cells from patients with osteoporosis. Journal of Cellular Biochemistry, 120, 16634–16642.
- Li, Y., Yang, F., Gao, M., Gong, R., Jin, M., Liu, T., … Yang, L. (2019). miR-149-3p regulates the switch between adipogenic and osteogenic differentiation of BMSCs by targeting FTO. Molecular Therapy—Nucleic Acids, 17, 590–600.
- Liao, L., Yu, Y., Shao, B., Su, X., Wang, H., Kuang, H., … Jin, Y. (2018). Redundant let-7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis. The FASEB Journal, 32, 1982–1992.
- Liu, H., Dong, Y., Feng, X., Li, L., Jiao, Y., Bai, S., … Zhao, Y. (2019). miR-34a promotes bone regeneration in irradiated bone defects by enhancing osteoblastic differentiation of mesenchymal stromal cells in rats. Stem Cell Research & Therapy, 10, 180.
- Liu, J., Dang, L., Li, D., Liang, C., He, X., Wu, H., … Zhang, G. (2015). A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Biomaterials, 52, 148–160.
- Luo, Z. W., Li, F. X., Liu, Y. W., Rao, S. S., Yin, H., Huang, J., … Xie, H. (2019). Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale, 11, 20884–20892.
- Lv, Y. J., Yang, Y., Sui, B. D., Hu, C. H., Zhao, P., Liao, L., … Jin, Y. (2018). Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice. Theranostics, 8, 2387–2406.
- Maruyama, Z., Yoshida, C. A., Furuichi, T., Amizuka, N., Ito, M., Fukuyama, R., … Komori, T. (2007). Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Developmental Dynamics, 236, 1876–1890.
- Mirsaidi, A., Kleinhans, K. N., Rimann, M., Tiaden, A. N., Stauber, M., Rudolph, K. L., & Richards, P. J. (2012). Telomere length, telomerase activity and osteogenic differentiation are maintained in adipose-derived stromal cells from senile osteoporotic SAMP6 mice. Journal of Tissue Engineering and Regenerative Medicine, 6, 378–390.
- Osman, A. M., Telity, S. A., Telity, S. A., Damanhouri, Z. A., Al-Harthy, S. E., Al-Kreathy, H. M., … Kamel, F. (2015). Chemosensitizing and nephroprotective effect of resveratrol in cisplatin -treated animals. Cancer Cell International, 15, 6.
- Ozturk, E., Arslan, A. K. K., Yerer, M. B., & BIshayee, A. (2017). Resveratrol and diabetes: A critical review of clinical studies. Biomedicine & Pharmacotherapy, 95, 230–234.
- Peng, H., Lu, S. L., Bai, Y., Fang, X., Huang, H., & Zhuang, X. Q. (2018). MiR-133a inhibits fracture healing via targeting RUNX2/BMP2. European Review for Medical and Pharmacological Sciences, 22, 2519–2526.
- Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015). Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43, e47.
- Shou, K., Huang, Y., Qi, B., Hu, X., Ma, Z., Lu, A., … Yu, A. (2018). Induction of mesenchymal stem cell differentiation in the absence of soluble inducer for cutaneous wound regeneration by a chitin nanofiber-based hydrogel. Journal of Tissue Engineering and Regenerative Medicine, 12, e867–e880.
- Song, H., Li, X., Zhao, Z., Qian, J., Wang, Y., Cui, J., … Su, J. (2019). Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Letters, 19, 3040–3048.
- Sui, L., Wang, M., Han, Q., Yu, L., Zhang, L., Zheng, L., … Chen, J. (2018). A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration. Biomaterials, 177, 88–97.
- Tang, Q., Hu, Z., Jin, H., Zheng, G., Yu, X., Wu, G., … Shen, L. (2019). Microporous polysaccharide multilayer coated BCP composite scaffolds with immobilised calcitriol promote osteoporotic bone regeneration both in vitro and in vivo. Theranostics, 9, 1125–1143.
- Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., Van de Weijer, T., Goossens, G. H., … Schrauwen, P. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabolism, 14, 612–622.
- Wang, X., Wu, J., Lin, Y., Zhu, Y., Xu, X., Xu, X., … Xie, L. (2014). MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting cyclin-dependent kinase 6. Journal of Experimental & Clinical Cancer Research, 33, 69.
- Wang, Z., Liu, Q., Liu, C., Tan, W., Tang, M., Zhou, X., … Deng, Y. (2019). Mg(2+) in beta-TCP/Mg-Zn composite enhances the differentiation of human bone marrow stromal cells into osteoblasts through MAPK-regulated Runx2/Osx. Journal of Cellular Physiology, 235, 5182–5191.
- Wilkesmann, S., Fellenberg, J., Nawaz, Q., Reible, B., Moghaddam, A., Boccaccini, A. R., & Westhauser, F. (2019). Primary osteoblasts, osteoblast precursor cells or osteoblast-like cell lines: Which human cell types are (most) suitable for characterizing 45S5-Bioglass? Journal of Biomedical Materials Research Part A, 108, 663–674.
- Wu, X., Wang, Q., Kang, N., Wu, J., Gu, C., Bi, J., … Xiao, R. (2017). The effects of different vascular carrier patterns on the angiogenesis and osteogenesis of BMSC-TCP-based tissue-engineered bone in beagle dogs. Journal of Tissue Engineering and Regenerative Medicine, 11, 542–552.
- Xie, Q., Wang, Z., Bi, X., Zhou, H., Wang, Y., Gu, P., & Fan, X. (2014). Effects of miR-31 on the osteogenesis of human mesenchymal stem cells. Biochemical and Biophysical Research Communications, 446, 98–104.
- Yang, F., Yan, G., Li, Y., Han, Z., Zhang, L., Chen, S., … Yang, L. (2016). Astragalus polysaccharide attenuated iron overload-induced dysfunction of mesenchymal stem cells via suppressing mitochondrial ROS. Cellular Physiology and Biochemistry, 39, 1369–1379.
- Yang, F., Yang, L., Li, Y., Yan, G., Feng, C., Liu, T., … Cai, B. (2017). Melatonin protects bone marrow mesenchymal stem cells against iron overload-induced aberrant differentiation and senescence. Journal of Pineal Research, 63, e12422.
- Zhan, F. L., Liu, X. Y., & Wang, X. B. (2018). The role of microRNA-143-5p in the differentiation of dental pulp stem cells into odontoblasts by targeting Runx2 via the OPG/RANKL signaling pathway. Journal of Cellular Biochemistry, 119, 536–546.
- Zhang, X., Li, Y., Chen, Y. E., Chen, J., & Ma, P. X. (2016). Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects. Nature Communications, 7, 10376.
- Zhang, Y., Xie, R. L., Croce, C. M., Stein, J. L., Lian, J. B., Van Wijnen, A. J., & Stein, G. S. (2011). A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proceedings of the National Academy of Sciences of the United States of America, 108, 9863–9868.
- Zheng, L., Tu, Q., Meng, S., Zhang, L., Yu, L., Song, J., … Chen, J. (2017). Runx2/DICER/miRNA pathway in regulating osteogenesis. Journal of Cellular Physiology, 232, 182–191.
- Zhao, L., Wang, Y., Wang, Z., Xu, Z., Zhang, Q., & Yin, M. (2015). Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. Journal of Nutritional Biochemistry, 26, 1174–1182.
- Zhou, T., Yan, Y., Zhao, C., Xu, Y., Wang, Q., & Xu, N. (2019). Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation. Redox Report, 24, 62–69.
- Zhu, Y. L., Wang, S., Ding, D. G., Xu, L., & Zhu, H. T. (2017). miR217 inhibits osteogenic differentiation of rat bone marrowderived mesenchymal stem cells by binding to Runx2. Molecular Medicine Reports, 15, 3271–3277.
- Zou, J., Zhang, Y., Sun, J., Wang, X., Tu, H., Geng, S., … Bi, Z. (2017). Deoxyelephantopin induces reactive oxygen species-mediated apoptosis and autophagy in human osteosarcoma cells. Cellular Physiology and Biochemistry, 42, 1812–1821.